10.35
price up icon0.39%   0.04
 
loading
Precedente Chiudi:
$10.31
Aprire:
$10.36
Volume 24 ore:
5.04M
Relative Volume:
0.55
Capitalizzazione di mercato:
$12.07B
Reddito:
$14.33B
Utile/perdita netta:
$-3.79B
Rapporto P/E:
-3.265
EPS:
-3.17
Flusso di cassa netto:
$1.84B
1 W Prestazione:
+1.77%
1M Prestazione:
+6.59%
6M Prestazione:
+28.89%
1 anno Prestazione:
-9.84%
Intervallo 1D:
Value
$10.34
$10.50
Intervallo di 1 settimana:
Value
$10.13
$10.52
Portata 52W:
Value
$6.85
$13.55

Viatris Inc Stock (VTRS) Company Profile

Name
Nome
Viatris Inc
Name
Telefono
(724) 514-1465
Name
Indirizzo
1000 MYLAN BOULEVARD, CANONSBURG
Name
Dipendente
32,000
Name
Cinguettio
Name
Prossima data di guadagno
2024-11-07
Name
Ultimi documenti SEC
Name
VTRS's Discussions on Twitter

Confronta VTRS con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Drug Manufacturers - Specialty & Generic icon
VTRS
Viatris Inc
10.35 12.02B 14.33B -3.79B 1.84B -3.17
Drug Manufacturers - Specialty & Generic icon
ZTS
Zoetis Inc
145.94 64.88B 9.39B 2.62B 2.22B 5.8121
Drug Manufacturers - Specialty & Generic icon
TAK
Takeda Pharmaceutical Co Adr
14.01 44.40B 29.96B 957.25M 4.77B 0.2956
Drug Manufacturers - Specialty & Generic icon
HLN
Haleon Plc Adr
9.25 41.72B 14.26B 1.98B 2.47B 0.4327
Drug Manufacturers - Specialty & Generic icon
TEVA
Teva Pharmaceutical Industries Ltd Adr
18.95 21.82B 16.70B -157.13M 1.19B -0.1446
Drug Manufacturers - Specialty & Generic icon
UTHR
United Therapeutics Corp
418.58 19.28B 3.08B 1.24B 1.07B 25.61

Viatris Inc Stock (VTRS) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2025-10-15 Iniziato Truist Buy
2025-06-06 Iniziato Goldman Neutral
2024-07-19 Ripresa Jefferies Buy
2023-10-23 Downgrade BofA Securities Neutral → Underperform
2023-06-23 Downgrade Barclays Equal Weight → Underweight
2023-04-24 Downgrade Barclays Overweight → Equal Weight
2023-02-17 Downgrade BMO Capital Markets Outperform → Market Perform
2023-01-27 Aggiornamento Jefferies Hold → Buy
2022-11-10 Aggiornamento UBS Sell → Neutral
2022-11-08 Aggiornamento Piper Sandler Underweight → Neutral
2022-10-21 Ripresa Jefferies Hold
2022-06-14 Iniziato UBS Sell
2022-05-10 Downgrade Piper Sandler Neutral → Underweight
2022-03-01 Downgrade BofA Securities Buy → Neutral
2022-03-01 Downgrade Raymond James Outperform → Mkt Perform
2021-06-15 Iniziato Citigroup Neutral
2021-04-07 Ripresa RBC Capital Mkts Outperform
2021-03-08 Downgrade Goldman Buy → Neutral
2021-03-02 Downgrade JP Morgan Overweight → Neutral
2021-02-26 Downgrade Wolfe Research Outperform → Peer Perform
2021-01-05 Iniziato Argus Hold
2020-12-14 Iniziato Bernstein Mkt Perform
Mostra tutto

Viatris Inc Borsa (VTRS) Ultime notizie

pulisher
04:04 AM

Can volume confirm reversal in Viatris Inc.Portfolio Profit Report & Growth Oriented Trade Recommendations - newser.com

04:04 AM
pulisher
03:53 AM

What’s the recovery path for long term holders of Viatris Inc.Weekly Risk Summary & Entry Point Confirmation Signals - newser.com

03:53 AM
pulisher
12:36 PM

Will Viatris Inc. stock return to pre crisis levels2025 Buyback Activity & Daily Profit Focused Screening - newser.com

12:36 PM
pulisher
Oct 25, 2025

Is Viatris Inc. stock a good choice for value investorsInsider Buying & Low Risk Entry Point Guides - newser.com

Oct 25, 2025
pulisher
Oct 25, 2025

Will Viatris Inc. stock benefit from upcoming earnings reportsJuly 2025 Snapshot & Target Return Focused Picks - newser.com

Oct 25, 2025
pulisher
Oct 25, 2025

Should you wait for a breakout in Viatris Inc.July 2025 Analyst Calls & AI Enhanced Trading Signals - newser.com

Oct 25, 2025
pulisher
Oct 25, 2025

Viatris updates bylaws and sets 2026 annual meeting for May 15 - Investing.com Canada

Oct 25, 2025
pulisher
Oct 24, 2025

What Occidental Petroleum’s Latest Backer Sees in Oil’s Next Chapter - The Motley Fool

Oct 24, 2025
pulisher
Oct 24, 2025

Viatris updates bylaws and sets 2026 annual meeting for May 15 By Investing.com - Investing.com South Africa

Oct 24, 2025
pulisher
Oct 24, 2025

Viatris Inc ($VTRS) CEO 2024 Pay Revealed - Quiver Quantitative

Oct 24, 2025
pulisher
Oct 24, 2025

Viatris Announces Approval of Amended Bylaws - TipRanks

Oct 24, 2025
pulisher
Oct 24, 2025

Viatris says second phase 3 trial of blurred vision drug meets goal - MSN

Oct 24, 2025
pulisher
Oct 24, 2025

What You Need to Know Ahead of Viatris' Earnings Release - Yahoo Finance

Oct 24, 2025
pulisher
Oct 24, 2025

Truist Initiates Viatris (VTRS) Coverage with Buy Rating, $15 PT - MSN

Oct 24, 2025
pulisher
Oct 24, 2025

Postmenopausal Osteoporosis Market Booming with Rapid Growth - openPR.com

Oct 24, 2025
pulisher
Oct 23, 2025

Can Viatris Inc. (VIA) stock sustain double digit ROEPrice Action & AI Forecasted Entry/Exit Points - newser.com

Oct 23, 2025
pulisher
Oct 23, 2025

Day 8 of Gains Streak for Viatris Stock with 6.9% Return (vs. -13% YTD) [10/22/2025] - Trefis

Oct 23, 2025
pulisher
Oct 22, 2025

Goldman Sachs Adjusts Price Target on Viatris to $12 From $11, Maintains Neutral Rating - MarketScreener

Oct 22, 2025
pulisher
Oct 21, 2025

Will Viatris (VTRS) Beat Estimates Again in Its Next Earnings Report? - sharewise.com

Oct 21, 2025
pulisher
Oct 21, 2025

Relative strength of Viatris Inc. in sector analysis2025 Growth vs Value & Technical Pattern Recognition Alerts - newser.com

Oct 21, 2025
pulisher
Oct 21, 2025

Can trapped investors hope for a rebound in Viatris Inc.2025 Dividend Review & Weekly Top Gainers Alerts - newser.com

Oct 21, 2025
pulisher
Oct 21, 2025

How Viatris is Fighting Infectious Disease - ACCESS Newswire

Oct 21, 2025
pulisher
Oct 21, 2025

Viatris Inc. (VTRS) Acquires Aculys Pharma, Inc - Insider Monkey

Oct 21, 2025
pulisher
Oct 21, 2025

What the charts say about Viatris Inc. todayTrade Entry Report & High Conviction Trade Alerts - newser.com

Oct 21, 2025
pulisher
Oct 21, 2025

World Mental Health Day 2025: Empowering Minds, Breaking Barriers - CSRwire

Oct 21, 2025
pulisher
Oct 20, 2025

Viatris Inc. Stock Rises Monday, Outperforms Market - 富途牛牛

Oct 20, 2025
pulisher
Oct 20, 2025

Viatris Inc. (VTRS) Stock Analysis: Navigating a 16.76% Potential Upside Amidst Market Challenges - DirectorsTalk Interviews

Oct 20, 2025
pulisher
Oct 20, 2025

Viatris buys Aculys Pharma to expand neurology portfolio in Japan - Medical Dialogues

Oct 20, 2025
pulisher
Oct 19, 2025

Viatris Inc.’s volatility index tracking explainedMarket Risk Report & Real-Time Buy Signal Alerts - newser.com

Oct 19, 2025
pulisher
Oct 18, 2025

How cyclical is Viatris Inc. (VIA) stock compared to rivals2025 Big Picture & Technical Entry and Exit Tips - nchmf.gov.vn

Oct 18, 2025
pulisher
Oct 18, 2025

Is Viatris Inc. stock vulnerable to regulatory risksTreasury Yields & Free Weekly Watchlist of Top Performers - nchmf.gov.vn

Oct 18, 2025

Viatris Inc Azioni (VTRS) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
drug_manufacturers_specialty_generic RDY
$14.58
price down icon 0.27%
$22.05
price up icon 1.29%
$48.78
price up icon 0.60%
$144.00
price up icon 0.23%
$418.58
price down icon 1.79%
Capitalizzazione:     |  Volume (24 ore):